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Abstract
Background:  Tachycardia is commonly observed in hypertensive patients, predominantly
mediated by regulatory mechanisms integrated within the autonomic nervous system. The genetic
loci and genes associated with increased heart rate in hypertension, however, have not yet been
identified.
Methods: An F2 intercross of Spontaneously Hypertensive Rats (SHR) × Brown Norway (BN)
linkage analysis of quantitative trait loci mapping was utilized to identify candidate genes associated
with an increased heart rate in arterial hypertension.
Results: Basal heart rate in SHR was higher compared to that of normotensive BN rats (365 ± 3
vs. 314 ± 6 bpm, p < 0.05 for SHR and BN, respectively). A total genome scan identified one
quantitative trait locus in a 6.78 cM interval on rat chromosome 8 (8q22–q24) that was responsible
for elevated heart rate. This interval contained 241 genes, of which 65 are known genes.
Conclusion: Our data suggest that an influential genetic region located on the rat chromosome 8
contributes to the regulation of heart rate. Candidate genes that have previously been associated
with tachycardia and/or hypertension were found within this QTL, strengthening our hypothesis
that these genes are, potentially, associated with the increase in heart rate in a hypertension rat
model.
Background
Heart rate is primarily determined by regulatory mecha-
nisms that are integrated within the autonomic nervous
system. In arterial hypertension, an increased heart rate is
commonly observed as a compensatory response to
decreased stroke volume (due to either a diastolic or systo-
lic myocardial dysfunction) [1,2]. Although an increased
basal heart rate, accompanying myocardial dysfunction,
might represent a secondary phenomenon in established
hypertension, an early increase in heart rate may contrib-
ute directly to the pathogenesis of the disease [3-6]. In
fact, tachycardia in arterial hypertension seems to be a
heritable trait and independent of reflex responses [7].
Few studies, however, have focused on the identification
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of the genetic basis of tachycardia related to hypertension.
A total genome scan to identify quantitative trait loci
(QTL) provides a powerful tool to determine the chromo-
somal location of alleles and polygenes that contribute to
complex diseases, such as autoimmune disorders [8,9],
cardiovascular diseases [10,11], cancer [12,13], infectious
diseases [14] and drug addiction [15,16].
Even though QTLs for complex diseases have been identi-
fied, little progress has been made towards the identifica-
tion of the genes related to complex traits such as
increased heart rate associated with hypertension.
Recently, Jaworski et al. [17] reported a QTL in rat chro-
mosome 2, centered around the D2Rat61/62 markers,
that is related to the air-puff stimulus-induced bradycar-
dia response. In agreement with Jaworski, Alemayehu et
al. [18] described a heart rate QTL involved in bradycar-
dia, induced by salt-load diet, on rat chromosome 2. We
previously mapped five QTL's (two on chromosome 2,
and one each on chromosomes 4, 8 and 16) involved in
blood pressure variation in an F2 population of an inter-
cross between Brown Norway (BN) and Spontaneously
hypertensive rats (SHR) [19]. In this study, we used link-
age analysis for QTL mapping and identification of candi-
date genes associated with basal levels of heart rate in the
progenies of an F2 rat intercross between the BN and SHR
strains.
Methods
Parental rat strain crosses and F2 phenotyping
To construct a detailed linkage map of all chromosomes
and determine the genetic traits for tachycardia associated
with hypertension we analyzed an intercross (F2) progeny
(N = 188 rats) of the BN and the SHR strains, and normo-
tensive (BN, N = 4) and hypertensive (SHR, N = 23) rats
as parental strains. All animals were genotyped for 179
polymorphic markers distributed along the rat genome,
according to a standard protocol [20]. Basal heart rate lev-
els of the F2 progeny were obtained from a previously
described phenotype database [19], and data from SHR
and BN strains (Medical School, University of São Paulo)
were evaluated in male 12–14 week old animals. Briefly,
an arterial polyethylene catheter (PE-10, 0.28 mm ID,
0.61 mm OD, Biocorp Australia, Huntingdale, Victoria,
Australia) was implanted under anesthesia (Pentobarbi-
tone sodium, 30 mg/kg, i.p.) into the abdominal aorta
through the left femoral artery at least 24 hours before
measurements. Blood pressure was measured in non-
anesthetized, freely moving rats, on a beat-to-beat basis at
a 1.0 KHz of sample rate (DataQ Instruments, Inc. Ohio,
USA) by connecting the arterial cannula to a pressure
transducer (Statham P23Dd, Hato Rey, Puerto Rico). The
pulse pressure signal from the transducer was fed to an
amplifier (GPA-4 model 2, Stemtech, Inc., Wood Dale, IL,
USA) and then to a 10-bit analog-to-digital converter
(DataQ Instruments, Inc., Akron, OH, USA). Basal heart
rate was derived from pulsatile blood pressure. All animal
experimental procedures were followed in accordance to
the guidelines for animal care and use of laboratory of the
University of São Paulo, Brazil and the protocol approved
by designated ethics committee.
Genetic marker map
The 188 animals from the F2 progeny were previously
genotyped for 179 genetic markers distributed along the
whole genome [19]. Although no new genotypes were
incorporated for this study, we have recently re-accessed
the genetic distances of each genotyped marker [21]
through sequential consultation of different internet data-
bases [22-24].
Quantitative trait loci (QTL) mapping
To assess the contribution of a putative QTL to the heart
rate trait, we used the composite interval mapping
method [25-28] in the F2 population (described above)
using the Windows QTL Cartographer [29]. We then
determined the significance of putative QTL's from the
interval mapping scan based on a likelihood ratio (LR)
threshold and considered 11.5 as suggestive linkage.
Criteria for candidate gene identification
Genes presented on the mapped heart rate QTL were listed
by consulting the public database of the rat genome [30].
The selection of candidate genes proceeded according to
the following criteria. Firstly, the known genes presented
in the mapped QTL were listed; secondly, the known
genes were submitted to gene ontology analysis
(described below) for refinement of selection; and finally,
genes were considered as candidate only if presented in a
heart rate related phenotype, confirmed by citations on
the NCBI PubMed browser [31].
Annotation of functional classes was carried out using
information provided by the Gene Ontology database
[32], accessed by NCBI's public repository [33]. The
known genes found in the QTL were classified in specific
function, process, or component classes through the GO
terms assignation. The genes belonging to the same class
were grouped and listed, and the candidate genes were
elected from the most frequent gene ontology terms or
according to gene ontology terms that are directly related
to the heart rate trait.
Statistical analysis
Kolmogorov-Smirnov test (with Lilliefors' correction) was
used to test data for normality of the estimated underlying
population using SigmaStat 3.11 (Systat Software, Inc.,
San Jose, CA, USA). Normality was assumed for all para-
metric tests and regression procedures. All phenotype
measurements (blood pressure and heart rate) were com-BMC Medical Genetics 2007, 8:17 http://www.biomedcentral.com/1471-2350/8/17
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pared between each parental strain (SHR × BN) using the
Student t test. Correlation between blood pressure and
heart rate values was performed calculating the Pearson r
correlation coefficient. Statistical significance was estab-
lish according to the P value (p < 0.05) for a two-tailed
distribution. All data are reported as mean ± SEM.
Results
Hemodynamic correlations
As expected, inbred parental strains had different levels of
basal blood pressure and heart rate (Table 1). Systolic
(188 ± 2 vs. 127 ± 5 mm Hg), diastolic (138 ± 2 vs. 91 ± 4
mm Hg), and mean (162 ± 2 vs. 109 ± 5 mm Hg) blood
pressure measurements were significantly increased in
SHR compared to the normotensive BN strain. Moreover,
the SHR strain presented an increase in heart rate levels
(365 ± 3 vs. 314 ± 6 bpm, p < 0.0001) compared to BN.
Although heart rate significantly correlated (p = 0.0069
for systolic blood pressure) with blood pressure levels
(Table 2), the R squared value suggested that these varia-
bles are poorly correlated only (0.0335 for systolic blood
pressure). Thus, we did not adjust heart rate values for
systolic or diastolic blood pressure traits before QTL map-
ping analysis.
QTL mapping
The linkage signals for the composite interval mapping
based on 179 markers along the 21 rat chromosomes (Fig-
ure 1) revealed the presence of a putative QTL responsible
for an increase in heart rate in chromosome 8 (Figure 1).
Figure 2 shows, in detail, the 6.78 cM heart rate QTL
mapped on rat chromosome 8 (8q22–q24), flanked by
APOA02 and R830 markers. In addition, the likelihood
ratio statistics for the higher linkage signal of the putative
QTL in chromosome 8 was 18.67. The estimated effects
on heart rate are -27.3 bpm for the additive and 5.3 bpm
for the dominant terms. Table 3 summarizes the allelic
effects on heart rate levels for the APOA02, R1106, and
R830 markers in homozygotes for either BN (BN/BN) and
SHR (SHR/SHR), and heterozygotes (BN/SHR) in the F2
intercross (SHR × BN) population. Although no signifi-
cant difference was observed in heart rate level for the
APOA02 (p = 0.7614) and the R830 (p = 0.8963) markers,
an allelic effect was observed for the R1106 marker (p =
0.0306). SHR homozygotes presented significantly lower
heart rate values compared to BN homozygotes (377 ± 6
vs. 370 ± 3 vs. 354 ± 8 bpm, for BN/BN, BN/SHR, and
SHR/SHR, respectively).
Candidate gene identification
The 6.78 cM heart rate QTL segment mapped on rat chro-
mosome 8 harbours 241 genes. When only known genes
were considered (Table 4), 176 genes were initially
excluded. Gene ontology analysis then revealed that most
of the 65 known genes were related to "metal ion bind-
ing", "protein binding", or "synaptic transmission" func-
tions, and some of these presented "receptor/transporter/
channel activity", some of which have an ion channel
activity (Chrna5, Chrna3, Chrnb4, Htr3a, Htr3b, Fxyd2,
and Hcn4). After gene ontology analysis, a further 48
genes were excluded, and 17 candidate genes remained.
Ten of the genes investigated (Bace1, Timm8b, Ncam1,
Slc37a4, Cul5, Fxyd2, Fxyd6, Ptpn9, Scamp2 and
Scamp5) did not display any association with the heart
rate trait and were eliminated. Candidate genes that were
associated with the heart rate trait are described in detail
in Table 5: Nicotinic acetylcholine receptor subtypes α3
(Chrna3), α5 (Chrna5), and β4 (Chrnb4); hyperpolariza-
tion-activated channel (Hcn4); 5-hydroxytryptamine
(serotonin) receptor 3a (Htr3a) and 3b (Htr3b); and
sodium channel (Scn2).
Discussion and conclusion
A number of reports studying hypertensive patients have
demonstrated an increased basal heart rate accompanying
myocardial dysfunction [1-6]. Furthermore, a positive
association between heart rate and all-cause mortality or
cardiovascular mortality has been observed [5,6]. As such,
it is important to elucidate the genetic factors that lead to
increased heart rate levels. Based on the observation of an
increased basal heart rate in the SHR strain, and using a
powerful genomic exploratory approach, we mapped a
new QTL on the rat chromosome 8 that is associated with
basal levels of heart rate in SHR and identified several
genes that could potentially be responsible for heart rate
modulation.
We, herein, show that the parental SHR strain displayed
increased heart rate values compared to normotensive BN
rats. Moreover, in the F2 intercross animals, the allelic
Table 1: Systolic (SBP), diastolic (DBP), and mean (MBP) blood pressure, and heart rate (HR) in normotensive (Brown Norway) and 
hypertensive (SHR) rat strains.
Brown Norway
(N = 04)
SHR
(N = 23)
p
SBP (mm Hg) 127 ± 5 188 ± 2 < 0.0001
DBP (mm Hg) 91 ± 4 138 ± 2 < 0.0001
MBP (mm Hg) 109 ± 5 162 ± 2 < 0.0001
HR (bpm) 314 ± 6 365 ± 3 < 0.0001BMC Medical Genetics 2007, 8:17 http://www.biomedcentral.com/1471-2350/8/17
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effects on heart rate levels for the R1106 marker suggest a
complex interaction of alleles. The average heart rate val-
ues were lower in the homozygote SHR allele compared
with the homozygote BN allele F2 animals. Furthermore,
we observed a negative allelic effect for the R1106 marker
(-22.9 bpm) that is concordant with the additive effect
obtained by composite interval mapping (-27.3 bpm).
These data suggest that the putative QTL, mapped on rat
chromosome 8, harbours gene(s) that negatively influ-
ence the heart rate levels. Moreover, it should be taken
into consideration that the algorithm of the composite
interval mapping method considers the influence of other
chromosomal regions or genes on the effect of the
mapped QTL.
Total genome scan analysis has contributed to the discov-
ery of several QTLs associated with different phenotypes
in complex diseases. However, although relative success
has been achieved in the identification of monogenic dis-
eases [34,35], limited progress has been made in the iden-
tification and confirmation of candidate genes in complex
diseases. Different chromosomal regions, associated with
heart rate-phenotype traits, have been mapped in both
patients and experimental animals [7,17,18,36,37].
Kreutz et al. [36] mapped a QTL on rat chromosome 3
that was associated with both basal heart rate and salt-
induced changes in heart rate in an F2 intercross (SHRSP
× WKY) population. Jaworski et al. [17] identified inde-
pendent chromosomal regions related to bradycardia in
response to mild stress (airpuff startle). Alemayehu et al.
[18] identified one putative heart rate locus on rat chro-
mosome 2 and confirmed its presence in different con-
genic strains after the substitution of the mapped interval
from the SHR for the allelic region of a normotensive
strain. Interestingly, Kren et al[38] reported a blood pres-
sure QTL on chromosome 8 which maps nearby the heart
rate-related QTL reported in the present study. However, a
congenic SHR-Lx strain harbouring this particular region
showed only changes in basal blood pressure and cardiac
mass with no heart rate effects. Therefore, it is less likely
that the same gene(s) are influencing the effects on heart
rate here described. In a mouse model, Sugiyama et al.
[37] conducted a QTL mapping analysis in an F2 progeny
(CBA/CaJ × BALB/cJ) and identified 3 loci associated with
heart rate, two on the mouse chromosome 2, and one on
chromosome 15. We, herein, mapped a new QTL located
in chromosome 8 and associated with a negative effect on
heart rate in the SHR. Kahn and collaborators [39] found
the rat chromosome 2 to be involved in heart rate, but
were not able to confirm their findings in a congenic
strain after the substitution of the mapped interval from
the SHR for the allelic region of a normotensive BN strain.
With regard to the rat chromosome 8, we previously
mapped a putative QTL [19], flanked by R19 and R850
markers, associated with salt-induced changes in blood
pressure that is located relatively close to the QTL, demon-
strated herein, that is associated with heart rate trait.
In humans, loci associated with the autonomic nervous
system's control of the heart rate have also been mapped
[7]. Singh et al. [7] investigated 725 patients from the
Framingham Heart Study and mapped 2 QTLs (chromo-
Table 3: Heart rate distributions, according to the genotype (BN/SHR, BN/SHR, or SHR/SHR), for the APOA02, R1106, and R830 
markers that flanked the heart rate QTL mapped in a 188 F2 (SHR × Brown Norway) population. 
Markers cM Heart rate by genotype One-way 
ANOVA (P)
Heart rate 
effect (bpm)
BN/BN BN/SHR SHR/SHR
APOA02 36.87 370 ± 8
(N = 43)
367 ± 3
(N = 91)
364 ± 4
(N = 46)
0.7614 5.81
R1106 38.10 377 ± 6
(N = 29)
370 ± 3
(N = 92)
354 ± 8*
(N = 37)
0.0306 22.87
R830 43.65 368 ± 8
(N = 41)
368 ± 3
(N = 91)
365 ± 4
(N = 43)
0.8963 3.20
*p < 0.05 when compared to BN/BN.
Note that heart rate effect (bpm) represents the heart rate difference between BN/BN and SHR/SHR genotypes.
Table 2: The correlation between heart rate and mean (MBP), diastolic (DBP) and systolic (SBP) blood pressures obtained in an F2 
(SHR × Brown Norway) population.
R-squared Pearson r Confidence interval P (two-tailed)
vs. MBP 0.0352 -0.1877 -0.3131 to -0.05587 0.0055
vs. DBP 0.0335 -0.1830 -0.3087 to -0.05098 0.0069
vs. SBP 0.0335 -0.1830 -0.3087 to -0.05105 0.0069BMC Medical Genetics 2007, 8:17 http://www.biomedcentral.com/1471-2350/8/17
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somes 2 and 15) associated with the frequency domain of
heart rate variability indexes. Although the authors [7]
have not mapped a QTL associated specifically with basal
heart rate, they proposed that the region contains genes
that share function for both basal heart rate and heart rate
variability traits. Interestingly, the QTL mapped on chro-
mosome 15 in humans is a syntenic region compared
with the interval we mapped for basal heart rate traits in
the rat chromosome 8.
In the present investigation, interval mapping revealed 17
genes that are potentially implicated in basal heart rate in
the SHR. Among these candidate genes, just 4 families of
genes were identified that maintained the association
with the heart rate phenotype after the use of certain selec-
tion criteria; these genes were Scn2b (Sodium channel
type II, beta polypeptide); Htr3a and Htr3b (5-Hydrox-
ytryptamine receptors type 3); Hcn4 (Hyperpolarization-
activated, cyclic nucleotide-gated K+  type 4); Chrna3,
Chrna5, and Chrnb4 (Neuronal nicotinic acetylcholine
receptor, alpha polypeptide 3 and 5, and beta polypeptide
4). Interestingly, association studies and genetic engi-
neered mice data support the involvement of some of the
heart rate candidate genes in arterial hypertension.
Knockout mice for the hyperpolarization-activated, cyclic
nucleotide – gated K+ 4 (HCN4) gene have cardiac cells
with "mature" pacemaker potentials, demonstrating that
this gene that encodes a hyperpolarization-activated chan-
nel is essential for the proper generation of pacemaker
potentials in the sinoatrial node [40]. In patients, a mis-
sense D553N mutation in the HCN4 gene was associated
with sinus node dysfunction, QT prolongation in the elec-
trocardiogram, polymorphic ventricular tachycardia, and
Likelihood ratio (LR) statistics for basal heart rate trait for all chromosomes in 188 rats from an F2 intercross (SHR × Brown  Norway) population Figure 1
Likelihood ratio (LR) statistics for basal heart rate trait for all chromosomes in 188 rats from an F2 intercross (SHR × Brown 
Norway) population. Each panel represents the chromosome number with the genetic length of the chromosome (cM) on the 
abscissa, and the horizontal dashed line denotes an LR score of 11.5 as the threshold for suggestive linkage.BMC Medical Genetics 2007, 8:17 http://www.biomedcentral.com/1471-2350/8/17
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syncope [41]. In addition, the presence of the S672R
mutation in the coding region of the HCN4 gene, mimics
a mild vagal stimulation in the sinoatrial node, slowing
the heart rate by decreasing the inward diastolic current
[42]. These data suggest that loss of function of the HCN4
gene is associated with sinus nodal dysfunction.
The neuronal nicotinic acetylcholine receptor (Chrn) sub-
types α3, α5, and β4 are members of a ligand-gated ion
channel family that affect sodium and potassium tran-
sients. Knockout mice strains lacking the genes encoding
the subtypes α5 and β4 of the nicotinic receptors showed
cardiac autonomic dysfunction, affecting the heart rate
response to vagal electrical stimulation. In humans,
although intragenic polymorphisms on the nicotinic
receptor subunits have been identified [43-45], these gene
mutations have not yet been associated with cardiovascu-
lar phenotypes.
One potential study limitation is the number of genetic
markers used in the genome-mapping experiment.
Although a large number of F2 analyses have been
reported, genes responsible for SHR hypertension and/or
heart rate related phenotypes have not been yet identified.
One of the possible explanations for this fact is the small
number of markers genotyped in these studies. We used
179 informative markers in our mapping experiment
using an intercross between the SHR and BN strains.
Although genetic distances and locations of these markers
were updated before conducting our analysis, it is possible
that QTLs important for the phenotype studied remain
unidentified.
Our data suggest that genetic markers on the rat chromo-
some 8 contribute to heart rate control in experimental
hypertension. The recognition of genetic determinants of
heart rate may help gain insights into the pathophysiol-
ogy of the autonomic nervous system and offer clues as to
its modulation in hypertension. Further studies will be
necessary to identify the specific gene(s) in chromosome
8 that are involved in hypertension-related tachychardia
and characterize the molecular mechanisms underlying
the genetic influence on heart rate in hypertensive rats.
Rat chromosome 8 heart rate QTL in 188 rats from an F2 intercross (SHR × Brown Norway) population Figure 2
Rat chromosome 8 heart rate QTL in 188 rats from an F2 intercross (SHR × Brown Norway) population. The horizontal 
dashed line denotes the likelihood ratio (LR) of 11.5 as the threshold for suggestive linkage. See Table 3 for details of markers 
delimiting the QTL and the effects on heart rate, according to genotype.BMC Medical Genetics 2007, 8:17 http://www.biomedcentral.com/1471-2350/8/17
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Table 4: Known genes present on the heart rate QTL mapped on SHR chromosome 8, and classified according to Gene Ontology 
(GO) terms.
GO Terms Gene ID Description
Axon Bace1 beta-site APP cleaving enzyme 1
Metabolism Mpi_mapped mannose phosphate isomerase (mapped)
Idh3a isocitrate dehydrogenase 3 (NAD+) alpha
Man2c1 mannosidase, alpha, class 2C, member 1
Pkm2 pyruvate kinase, muscle
Metal Ion Binding Pts 6-pyruvoyl-tetrahydropterin synthase
Fdx1 ferredoxin 1
Cyp19 cytochrome P450, subfamily 19
Cyp1a2 cytochrome P450, 1a2
Cyp11a cytochrome P450, subfamily 11A
Ireb2 iron-regulatory protein 2
Isl2 insulin related protein 2
Cox5a cytochrome c oxidase, subunit Va
Nucleus Cryab crystallin, alpha B
Atm_mapped ataxia telangiectasia mutated homolog (human) (mapped)
Protein Folding/Processing Hspb2 heat shock 27 kD protein 2
Hyou1 hypoxia up-regulated 1
Pcsk7 proprotein convertase subtilisin/kexin, type 7
Protein Binding Mcam l-gicerin
Thy1 thymus cell antigen 1, theta
Usp2 ubiquitin specific protease 2
Zbtb16 zinc finger and BTB domain containing 16
Cul5 vasopressin-activated calcium-mobilizing receptor protein
Rcn2 reticulocalbin 2
Cd3d CD3 antigen delta polypeptide
Tagln transgelin
Receptor/Transporter/Channel Activity Blr1 Burkitt lymphoma receptor 1
Il10ra interleukin 10 receptor, alpha
Neo1 neogenin
Slc37a4 solute carrier family 37 (glycerol-6-phosphate transporter), member 4
Fxyd2 FXYD domain-containing ion transport regulator 2
Fxyd6 FXYD domain-containing ion transport regulator 6
Hcn4 hyperpolarization-activated, cyclic nucleotide-gated K+ 4
Timm8b translocase of inner mitochondrial membrane 8 homolog b (yeast)
Scamp2 secretory carrier membrane protein 2
Scamp5 secretory carrier membrane protein 5
Synaptic Transmission Chrna5 cholinergic receptor, nicotinic, alpha polypeptide 5
Chrna3 cholinergic receptor, nicotinic, alpha polypeptide 3
Chrnb4 cholinergic receptor, nicotinic, beta polypeptide 4
Scn2b sodium channel, voltage-gated, type II, beta polypeptide
Htr3b 5-hydroxytryptamine (serotonin) receptor 3b
Htr3a 5-hydroxytryptamine (serotonin) receptor 3a
Ncam1 neural cell adhesion molecule 1
Transferase Activity Hmbs hydroxymethylbilane synthase
Dlat dihydrolipoamide acetyltransferase
Acat1 acetyl-coenzyme A acetyltransferase 1
Clk3 CDC-like kinase 3
Other Terms Rps25 ribosomal protein s25
Treh trehalaseBMC Medical Genetics 2007, 8:17 http://www.biomedcentral.com/1471-2350/8/17
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Table 5: Associated phenotypes described for 13 candidate genes present on the heart rate QTL, mapped on SHR chromosome 8.
Gene Name Associated phenotype Reference
Chrna3
Chrna5
Chrnb4
Cholinergic receptor, nicotinic, alpha 
polypeptide 3 and 5, and beta 
polypeptide 4
- Autonomic nervous system influence on heart rate;
- Alzheimer's disease;
- Autosomal dominant nocturnal frontal lobe epilepsy.
Bonati et al., 2000 [46]
Bonati et al., 2002 [47]
Duga et al., 2001 [43]
Kawamata et al., 2002 [48]
Lev-Lehman et al., 2001 [44]
Liang Y 2005 [49]
Rassadi, S 2005 [50]
Rempel et al., 1998 [45]
Wang et al., 2002 [51]
Wang et al., 2003 [52]
Hcn4 Hyperpolarization-activated, cyclic 
nucleotide – gated K+ 4
- Familial sinus bradycardia;
- Generation of pacemaker potentials in the sinoatrial 
node;
- Cardiac arrhythmia.
Leoni et al., 2005 [53]
Milanesi et al., 2006 [42]
Schulze-Bahr et al., 2003 [54]
Stieber et al., 2006 [55]
Stieber et al., 2003 [40]
Ueda et al., 2004 [41]
Htr3a
Htr3b
5-hydroxytryptamine (serotonin) 
receptor 3a and 3b
- Modulatory role in the reflex control of the heart 
rate by cardiopulmonary receptors;
- Nausea induced by paroxetine;
- Fibromyalgia;
- Numerous human neuropsychiatric disorders (female 
major depression, bipolar affective and schizophrenic).
Aviado et al., 2001 [56]
Frank et al., 2004 [57]
Yamada et al., 2006 [58]
Iidaka et al., 2005 [59]
Niesler et al., 2001 [60]
Sevoz et al., 1997 [61]
Sugai et al., 2006 [62]
Thoren, 1979 [63]
Whalen et al., 2000 [64]
Scn2b Sodium channel, voltage-gated, type 
II, beta polypeptide
- Essential hypertension;
- Liddle's syndrome;
- Idiopathic generalized epilepsy;
- Neuropathic pain;
- Cell adhesion and migration;
- Chronic Heart Failure.
Baker et al., 1998 [65]
Botero-Velez et al., 1994 [66]
Dong et al., 2002 [67]
Haug et al., 2000 [68]
Kim et al., 2005 [69]
Pegoraro RJ et al., 2004 [70]
Pertin et al., 2005 [71]
Schild et al., 1996 [72]
Snyder et al., 1995 [73]
Su et al., 1996 [74]
Rayner et al., 2003 [75]
Zicha S et al., 2004 [76]
Pafah1b2 platelet-activating factor acetylhydrolase alpha 2 subunit (PAF-AH alpha 2)
Apoa5 apolipoprotein A-V
Tmprss5 transmembrane protease, serine 5 (spinesin)
Il18 interleukin 18
Crabp1_mapped cellular retinoic acid binding protein I (mapped)
Psma4 proteasome (prosome, macropain) subunit, alpha type 4
Cspg4 membrane-spanning proteoglycan NG2
Ptpn9 protein tyrosine phosphatase, non-receptor type 9
Sdfr1 stromal cell derived factor receptor 1
Hexa hexosaminidase A
Myo9a myosin IXA
Ube4a ubiquitin conjugation factor E4 A
Cd276 CD276 antigen
No Terms Phldb1 pleckstrin homology-like domain, family B, member 1
Crgl2 olfactomedin-related protein
Znf291 KIAA1454-like protein
Table 4: Known genes present on the heart rate QTL mapped on SHR chromosome 8, and classified according to Gene Ontology 
(GO) terms. (Continued)BMC Medical Genetics 2007, 8:17 http://www.biomedcentral.com/1471-2350/8/17
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